
Corporate venture fund of Merck investing in digital health companies worldwide

Corporate venture fund from Merck investing in digital health and healthcare technology companies worldwide

The Merck Global Health Innovation Fund, usually shortened to GHI, is the venture arm of the Merck pharmaceutical group. It says it is changing how corporate healthcare venture capital works by building a healthcare ecosystem strategy around its investments, and it reports more than sixty digital health deals. The fund invests across the world, with most of its attention on North America and Europe, and it puts money into platform companies whose technology or business model is already proven and where Merck's expertise can speed up revenue growth.
The fund describes its typical focus areas, with an emphasis on therapeutic areas where Merck is strong, oncology, the central nervous system, immunology and virology:
Typical investments are companies that already have revenue, are close to profitability and want growth capital. The fund adds the weight of a strategic backer to a venture style of working: a streamlined process with the autonomy to make deals, a senior team with healthcare operating experience, and access to science, supply chain, commercial, marketing and regulatory specialists inside the parent group. It also points to Merck's operations and people in more than 140 countries and to a function that arranges collaborations between portfolio companies and the wider group.
Merck GHIF, the Merck Global Health Innovation Fund, is the corporate venture arm of Merck. It backs digital health companies around the world, aiming to help them grow using the resources and healthcare expertise of its parent group.
The fund invests in healthcare technology companies, with a therapeutic emphasis on oncology, central nervous system disorders, immunology and virology. It also makes selective early-stage bets on emerging technologies.
Summary written by TrustList from the business's own published information, Nov 2026.
2 images - click to enlarge
Used it? Your experience helps other buyers decide.
Write a reviewNo questions yet. Be the first to ask about Merck GHIF.
Similar listings buyers compare against this one.

Corporate venture fund of Merck investing in digital health companies worldwide

Corporate venture arm of Northwestern Mutual investing in financial, health and analytics technology, plus a Wisconsin startup fund

Marketing technology group, formerly known as You & Mr Jones, that runs agencies and a venture arm

Pre-seed and seed investor in software and Web3 startups, active since 2019

Family of investment partnerships covering public equities, private placements and venture capital

Venture capital investor focused on seed and early-round technology companies, backed by cyber, construction and banking experience

Early-stage B2B venture capital firm backed by experienced enterprise operators who invest alongside it

Early-stage venture capital firm backing technology founders, based in Dallas
Everything here links back to the same verified catalogue. Pick your next stop.